Subscribe
Subscription banner for an ophthalmic newsletter
FDA Accepts Oxular’s IND Application for the Treatment of Diabetic Macular Edema

The U.S. Food and Drug Administration has approved Oxular Limited's investigational new drug applica...

read more
FDA Accepts Oxular’s IND Application for the Treatment of Diabetic Macular Edema
January 26, 2023
More